01 September 2005
Alteration in spectral properties on ligand binding reveals flexibility inmonoamine oxidase.
Rona R Ramsay, Tadeusz Z.E. Jones, Robert M.G. HynsonMed Sci Monit 2005; 11(9): SR15-20 :: ID: 428462
Abstract
Crystal structures have opened the door to understanding the mechanismand ligand specificities of MAO A and MAO B. We review here functional properties that suggest a flexibilityin MAO that is likely to influence catalysis under different cellular conditions. The flexibility indicatedby altered oxidation kinetics and a changed redox potential in the presence of a substrate was confirmedby circular dichroism spectroscopy. Circular dichroism also demonstrated alterations in the conformationof aromatic residues during reduction of MAO A and after covalent modification of the flavin. Visiblespectra provide a convenient way to monitor ligand binding in the active site. Different groups nearthe flavin give different spectral changes. During reduction of MAO A, a distinct 412 nm peak appearsafter partial reduction. Recent work suggests that this may be a tyrosyl radical in equilibrium withthe semiquinone of the flavin. Substrates prevent the appearance of the 412 nm peak but many inhibitorsenhance it by preventing further reduction. We propose that steric effects in the active site could bethe mechanism of this difference. Flexibility is also important for the transmission of the effects ofmodifying the surface thiols to the active site. Modification of multiple thiols results in inactivationbut mutation of a single thiol, cysteine 374 in MAO A to alanine, decreased the catalytic potency (kcat/Km)by 30%. Thus, surface modification of MAO (for example, by oxidative stress) could reduce its activity.
Keywords: Cysteine - chemistry, Catalytic Domain, Allosteric Regulation, Kinetics, Ligands, Models, Molecular, Monoamine Oxidase - metabolism, Monoamine Oxidase Inhibitors - pharmacology, Oxidation-Reduction, Protein Conformation
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952